FDA Drug Application (076491) for TRILYTE by MEDA PHARMS

Back to FDA Applications sponsored by MEDA PHARMS

Application Number076491
Product Number001
FormFOR SOLUTION;ORAL
Dosage420GM/BOT;1.48GM/BOT;5.72GM/BOT;11.2GM/BOT
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AA Products in conventional dosage forms not presenting bioequivalence problems
Reference Drug
Drug NameTRILYTE
Active IngredientPOLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Active IngredientCount
List of drugs with Active Ingredient POLYETHYLENE GLYCOL 335028
List of drugs with Active Ingredient POTASSIUM CHLORIDE279
List of drugs with Active Ingredient SODIUM BICARBONATE53
List of drugs with Active Ingredient SODIUM CHLORIDE352


Back to FDA Applications sponsored by MEDA PHARMS